Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly

被引:19
作者
Bell, GM
Schnitzer, TJ
机构
[1] Abgenix Inc, Fremont, CA 94555 USA
[2] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Sch Med, Off Clin Res & Training, Chicago, IL 60611 USA
关键词
D O I
10.1016/S0749-0690(05)70082-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed therapies for acute and chronic pain in the elderly. NSAIDs are effective in treating many disorders, but their use often is limited by toxicities, especially gastrointestinal and renal toxicity. COX-2 inhibitors are a major therapeutic advance, providing the analgesic and anti-inflammatory activity of NSAIDs, with a significant improvement in gastrointestinal safety. These new agents may be ideal therapies for older patients at risk for NSAID-related gastrointestinal toxicity.
引用
收藏
页码:489 / +
页数:15
相关论文
共 55 条
  • [1] Bjorkman David J., 1999, American Journal of Medicine, V107, p3S
  • [2] Colorectal cancer prevention and treatment
    Boland, CR
    Sinicrope, FA
    Brenner, DE
    Carethers, JM
    [J]. GASTROENTEROLOGY, 2000, 118 (02) : S115 - S128
  • [3] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    Day, R
    Ferraz, MB
    Hawkey, CJ
    Hochberg, MC
    Kvien, TK
    Schnitzer, TJ
    Weaver, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
  • [4] Boyce EG, 1999, FORMULARY, V34, P405
  • [5] Brater D. Craig, 1999, American Journal of Medicine, V107, p65S
  • [6] Cannon GW, 2000, ARTHRITIS RHEUM-US, V43, P978, DOI 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO
  • [7] 2-0
  • [8] Crofford LJ, 2000, ARTHRITIS RHEUM-US, V43, P4, DOI 10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO
  • [9] 2-V
  • [10] Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans
    Cryer, B
    Feldman, M
    [J]. GASTROENTEROLOGY, 1999, 117 (01) : 17 - 25